Molecular Templates Corporate Presentation August 2024

Molecular Templates presents its proprietary Engineered Toxin Body (ETB) technology platform for next-generation antibody-drug conjugates. The presentation covers clinical programs including MT-6402, MT-5111, MT-0169, and MT-8421, highlighting the ETB mechanism of action leveraging de-immunized Shiga-like toxin A-subunit payloads for oncology and autoimmune applications.